Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) Non Operating Income (2022 - 2026)

Cannabis Bioscience International Holdings filings provide 5 years of Non Operating Income readings, the most recent being -$10675.0 for Q1 2026.

  • On a quarterly basis, Non Operating Income rose 79.47% to -$10675.0 in Q1 2026 year-over-year; TTM through Feb 2026 was -$116470.0, a 25.77% increase, with the full-year FY2025 number at -$127455.0, up 22.85% from a year prior.
  • Non Operating Income reached -$10675.0 in Q1 2026 per CBIH's latest filing, up from -$21090.0 in the prior quarter.
  • The five-year high for Non Operating Income was $21299.0 in Q3 2024, with the low at -$106302.0 in Q2 2024.
  • A 5-year average of -$31049.9 and a median of -$25503.0 in 2023 define the central range for Non Operating Income.
  • Peak annual rise in Non Operating Income hit 525.55% in 2024, while the deepest fall reached 9502.71% in 2024.
  • Year by year, Non Operating Income stood at -$36278.0 in 2022, then grew by 17.54% to -$29916.0 in 2023, then soared by 33.48% to -$19901.0 in 2024, then fell by 5.97% to -$21090.0 in 2025, then soared by 49.38% to -$10675.0 in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Non Operating Income are -$10675.0 (Q1 2026), -$21090.0 (Q4 2025), and -$7861.0 (Q3 2025).